| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/11/2026 | ±5.6% | -1.7% | over-priced |
| 06/22/2026 | ±4.7% | -5.0% | under-priced |
| 03/11/2026 | ±4.3% | +9.2% | under-priced |
| 12/11/2025 | ±3.1% | -10.8% | under-priced |
| 09/10/2025 | ±3.2% | +36.0% | under-priced |
| 06/18/2025 | ±5.8% | +1.3% | over-priced |
| 03/11/2025 | ±5.7% | -3.1% | over-priced |
| 12/10/2024 | ±3.1% | -6.7% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.56 | $19.3B | $4.8B |
| Q4 FY2026 | — | $14.8B | $2.5B |
| Q3 FY2026 | $1.27 | $17.2B | $3.7B |
| Q2 FY2026 | $2.10 | $16.1B | $6.1B |
Oracle Corp (ORCL) reports in 44 days, with the next report estimated for 12/11/2026. Across the last 8 reports, options priced an average ±4.4% earnings move while the stock actually moved 9.2% on average — the market has been roughly fair on ORCL's earnings risk. Fundamentals into the print: EPS up 54.5% year-over-year, revenue up 29.6%. QuantLogix's live 5-factor engine currently reads ORCL as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →